Listed

Fulcrum Therapeutics, Inc.

FULCNasdaqCIK 1680581HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$29.3m, Q2 FY2026
Net income−$26.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.8Revenue, Q3 FY2023, three months to 2023-09-30$759.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure0.9Revenue, Q4 FY2023, three months to 2023-12-31$871.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-02-25, accession 0000950170-25-026068. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-05-13, accession 0000950170-24-058193.Report this figure80.0Revenue, Q2 FY2024, three months to 2024-06-30$80.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m18.2Research and development, Q3 FY2023, three months to 2023-09-30$18.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure19.0Research and development, Q4 FY2023, three months to 2023-12-31$19.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-25, accession 0000950170-25-026068. Derived: 12-month figure less the 9-month figure.Report this figure19.8Research and development, Q1 FY2024, three months to 2024-03-31$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure17.3Research and development, Q2 FY2024, three months to 2024-06-30$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure14.6Research and development, Q3 FY2024, three months to 2024-09-30$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure11.7Research and development, Q4 FY2024, three months to 2024-12-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure13.4Research and development, Q1 FY2025, three months to 2025-03-31$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure13.0Research and development, Q2 FY2025, three months to 2025-06-30$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure14.3Research and development, Q3 FY2025, three months to 2025-09-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure15.4Research and development, Q4 FY2025, three months to 2025-12-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure14.1Research and development, Q1 FY2026, three months to 2026-03-31$14.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure12.4Research and development, Q2 FY2026, three months to 2026-06-30$12.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Operating income$m(27.4)Operating income, Q3 FY2023, three months to 2023-09-30−$27.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure(28.0)Operating income, Q4 FY2023, three months to 2023-12-31−$28.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-25, accession 0000950170-25-026068. Derived: 12-month figure less the 9-month figure.Report this figure(29.8)Operating income, Q1 FY2024, three months to 2024-03-31−$29.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure52.5Operating income, Q2 FY2024, three months to 2024-06-30$52.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure(25.1)Operating income, Q3 FY2024, three months to 2024-09-30−$25.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure(19.4)Operating income, Q4 FY2024, three months to 2024-12-31−$19.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure(20.4)Operating income, Q1 FY2025, three months to 2025-03-31−$20.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(19.8)Operating income, Q2 FY2025, three months to 2025-06-30−$19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure(21.9)Operating income, Q3 FY2025, three months to 2025-09-30−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure(22.7)Operating income, Q4 FY2025, three months to 2025-12-31−$22.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure(22.2)Operating income, Q1 FY2026, three months to 2026-03-31−$22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(29.3)Operating income, Q2 FY2026, three months to 2026-06-30−$29.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Net income$m(24.0)Net income, Q3 FY2023, three months to 2023-09-30−$24.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure(24.8)Net income, Q4 FY2023, three months to 2023-12-31−$24.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-25, accession 0000950170-25-026068. Derived: 12-month figure less the 9-month figure.Report this figure(26.9)Net income, Q1 FY2024, three months to 2024-03-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure55.4Net income, Q2 FY2024, three months to 2024-06-30$55.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure(21.7)Net income, Q3 FY2024, three months to 2024-09-30−$21.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure(16.6)Net income, Q4 FY2024, three months to 2024-12-31−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure(17.7)Net income, Q1 FY2025, three months to 2025-03-31−$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure(17.3)Net income, Q2 FY2025, three months to 2025-06-30−$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure(19.6)Net income, Q3 FY2025, three months to 2025-09-30−$19.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure(20.3)Net income, Q4 FY2025, three months to 2025-12-31−$20.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure(18.9)Net income, Q1 FY2026, three months to 2026-03-31−$18.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure(26.2)Net income, Q2 FY2026, three months to 2026-06-30−$26.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Diluted EPS$ per share(0.39)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figurenot reported(0.43)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure0.87Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure(0.35)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(0.28)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure(0.31)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figurenot reported(0.25)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(0.34)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Basic EPS$ per share(0.39)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figurenot reported(0.43)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure0.89Basic EPS, Q2 FY2024, three months to 2024-06-30$0.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure(0.35)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figurenot reported(0.28)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(0.28)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure(0.31)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figurenot reported(0.25)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(0.34)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure

Balance sheet

Cash and equivalents$48.5m, Q2 FY2026
Shareholders' equity$310.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m30.1Cash and equivalents, Q3 FY2023, at 2023-09-30$30.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure25.6Cash and equivalents, FY2023, at 2023-12-31$25.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-25, accession 0000950170-25-026068.Report this figure39.9Cash and equivalents, Q1 FY2024, at 2024-03-31$39.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure86.7Cash and equivalents, Q2 FY2024, at 2024-06-30$86.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure72.6Cash and equivalents, Q3 FY2024, at 2024-09-30$72.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure58.2Cash and equivalents, FY2024, at 2024-12-31$58.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001193125-26-065197.Report this figure42.2Cash and equivalents, Q1 FY2025, at 2025-03-31$42.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure42.6Cash and equivalents, Q2 FY2025, at 2025-06-30$42.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure47.1Cash and equivalents, Q3 FY2025, at 2025-09-30$47.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure198Cash and equivalents, FY2025, at 2025-12-31$197.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure50.3Cash and equivalents, Q1 FY2026, at 2026-03-31$50.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure48.5Cash and equivalents, Q2 FY2026, at 2026-06-30$48.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Current assets$m262Current assets, Q3 FY2023, at 2023-09-30$262.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-059755.Report this figure242Current assets, FY2023, at 2023-12-31$242.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0000950170-25-026068.Report this figure218Current assets, Q1 FY2024, at 2024-03-31$218.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058193.Report this figure280Current assets, Q2 FY2024, at 2024-06-30$280.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-31, accession 0000950170-24-088238.Report this figure267Current assets, Q3 FY2024, at 2024-09-30$267.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure250Current assets, FY2024, at 2024-12-31$249.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065197.Report this figure233Current assets, Q1 FY2025, at 2025-03-31$232.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure219Current assets, Q2 FY2025, at 2025-06-30$219.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure206Current assets, Q3 FY2025, at 2025-09-30$205.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure357Current assets, FY2025, at 2025-12-31$357.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure339Current assets, Q1 FY2026, at 2026-03-31$338.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure323Current assets, Q2 FY2026, at 2026-06-30$322.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Total assets$m279Total assets, Q3 FY2023, at 2023-09-30$278.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-059755.Report this figure258Total assets, FY2023, at 2023-12-31$257.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0000950170-25-026068.Report this figure233Total assets, Q1 FY2024, at 2024-03-31$232.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058193.Report this figure294Total assets, Q2 FY2024, at 2024-06-30$294.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-31, accession 0000950170-24-088238.Report this figure279Total assets, Q3 FY2024, at 2024-09-30$279.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure261Total assets, FY2024, at 2024-12-31$260.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001193125-26-065197.Report this figure243Total assets, Q1 FY2025, at 2025-03-31$242.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure229Total assets, Q2 FY2025, at 2025-06-30$228.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure215Total assets, Q3 FY2025, at 2025-09-30$214.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure366Total assets, FY2025, at 2025-12-31$366.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure347Total assets, Q1 FY2026, at 2026-03-31$346.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure324Total assets, Q2 FY2026, at 2026-06-30$324.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Current liabilities$m14.1Current liabilities, Q3 FY2023, at 2023-09-30$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-059755.Report this figure13.7Current liabilities, FY2023, at 2023-12-31$13.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0000950170-25-026068.Report this figure10.7Current liabilities, Q1 FY2024, at 2024-03-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058193.Report this figure12.7Current liabilities, Q2 FY2024, at 2024-06-30$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-31, accession 0000950170-24-088238.Report this figure14.5Current liabilities, Q3 FY2024, at 2024-09-30$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure11.0Current liabilities, FY2024, at 2024-12-31$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065197.Report this figure8.1Current liabilities, Q1 FY2025, at 2025-03-31$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure9.0Current liabilities, Q2 FY2025, at 2025-06-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure11.6Current liabilities, Q3 FY2025, at 2025-09-30$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure13.0Current liabilities, FY2025, at 2025-12-31$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure9.9Current liabilities, Q1 FY2026, at 2026-03-31$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure10.3Current liabilities, Q2 FY2026, at 2026-06-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Total liabilities$m23.4Total liabilities, Q3 FY2023, at 2023-09-30$23.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-059755.Report this figure22.5Total liabilities, FY2023, at 2023-12-31$22.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0000950170-25-026068.Report this figure19.0Total liabilities, Q1 FY2024, at 2024-03-31$19.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058193.Report this figure20.5Total liabilities, Q2 FY2024, at 2024-06-30$20.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-31, accession 0000950170-24-088238.Report this figure21.7Total liabilities, Q3 FY2024, at 2024-09-30$21.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure17.7Total liabilities, FY2024, at 2024-12-31$17.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001193125-26-065197.Report this figure14.2Total liabilities, Q1 FY2025, at 2025-03-31$14.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure14.5Total liabilities, Q2 FY2025, at 2025-06-30$14.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure16.5Total liabilities, Q3 FY2025, at 2025-09-30$16.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure17.3Total liabilities, FY2025, at 2025-12-31$17.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure13.5Total liabilities, Q1 FY2026, at 2026-03-31$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure13.3Total liabilities, Q2 FY2026, at 2026-06-30$13.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure
Shareholders' equity$m255Shareholders' equity, Q3 FY2023, at 2023-09-30$255.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure235Shareholders' equity, FY2023, at 2023-12-31$235.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001193125-26-065197.Report this figure214Shareholders' equity, Q1 FY2024, at 2024-03-31$213.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure274Shareholders' equity, Q2 FY2024, at 2024-06-30$273.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure257Shareholders' equity, Q3 FY2024, at 2024-09-30$257.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure243Shareholders' equity, FY2024, at 2024-12-31$243.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure228Shareholders' equity, Q1 FY2025, at 2025-03-31$228.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure214Shareholders' equity, Q2 FY2025, at 2025-06-30$214.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure198Shareholders' equity, Q3 FY2025, at 2025-09-30$198.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure349Shareholders' equity, FY2025, at 2025-12-31$349.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure333Shareholders' equity, Q1 FY2026, at 2026-03-31$333.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure311Shareholders' equity, Q2 FY2026, at 2026-06-30$310.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure

Cash flow

Operating cash flow−$16.0m, Q2 FY2026
Capital expenditure$108.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(22.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$22.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-125931. Derived: 9-month figure less the 6-month figure.Report this figure(23.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$23.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-25, accession 0000950170-25-026068. Derived: 12-month figure less the 9-month figure.Report this figure(25.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$25.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure58.9Operating cash flow, Q2 FY2024, three months to 2024-06-30$58.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-29, accession 0000950170-25-099407. Derived: 6-month figure less the 3-month figure.Report this figure(19.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$19.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001193125-25-254633. Derived: 9-month figure less the 6-month figure.Report this figure(16.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(13.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-326098. Derived: 6-month figure less the 3-month figure.Report this figure(14.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001193125-25-254633. Derived: 9-month figure less the 6-month figure.Report this figure(16.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure(18.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure(16.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$16.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-326098. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$65.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0000950170-24-125931. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$77.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-25, accession 0000950170-25-026068. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$28.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-29, accession 0000950170-25-099407. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001193125-25-254633. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$231.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$65.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-326098. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001193125-25-254633. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$159.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-065197. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$108.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-326098. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)76.26m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q1 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3046,213 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-059755.Report this figure0.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3159,722 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058193.Report this figure61.8Diluted shares (weighted), Q1 FY2023, three months to 2023-06-3061,794,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-31, accession 0000950170-24-088238.Report this figure61.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3061,823,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-125931.Report this figure62.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3161,984,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0000950170-25-061442.Report this figure63.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3063,587,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-29, accession 0000950170-25-099407.Report this figure62.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3062,409,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure62.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3162,479,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure62.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3062,544,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure62.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3062,597,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001193125-25-254633.Report this figure76.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3176,215,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-27, accession 0001193125-26-178814.Report this figure76.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3076,264,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure

Shares outstanding: 76.30mShares outstanding, period not labelled, at 2026-07-2376,297,257 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-30, accession 0001193125-26-326098.Report this figure at Jul 23, 2026, from the cover of the 10-Q filed Jul 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.